129 related articles for article (PubMed ID: 16908139)
21. Intermolecular interactions in the crystal structures of potential HIV-1 integrase inhibitors.
Majerz-Maniecka K; Musiol R; Nitek W; Oleksyn BJ; Mouscadet JF; Le Bret M; Polanski J
Bioorg Med Chem Lett; 2006 Feb; 16(4):1005-9. PubMed ID: 16289813
[TBL] [Abstract][Full Text] [Related]
22. Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors.
Sato M; Kawakami H; Motomura T; Aramaki H; Matsuda T; Yamashita M; Ito Y; Matsuzaki Y; Yamataka K; Ikeda S; Shinkai H
J Med Chem; 2009 Aug; 52(15):4869-82. PubMed ID: 19719237
[TBL] [Abstract][Full Text] [Related]
23. New 4-[(1-benzyl-1H-indol-3-yl)carbonyl]-3-hydroxyfuran-2(5H)-ones, beta-diketo acid analogs as HIV-1 integrase inhibitors.
Ferro S; Barreca ML; De Luca L; Rao A; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
Arch Pharm (Weinheim); 2007 Jun; 340(6):292-8. PubMed ID: 17562561
[TBL] [Abstract][Full Text] [Related]
24. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
Wang Z; Vince R
Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the strand transfer step of HIV-1 integrase by non-natural dinucleotides.
Chi G; Neamati N; Nair V
Bioorg Med Chem Lett; 2004 Oct; 14(19):4815-7. PubMed ID: 15341930
[TBL] [Abstract][Full Text] [Related]
27. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.
Li H; Wang C; Sanchez T; Tan Y; Jiang C; Neamati N; Zhao G
Bioorg Med Chem; 2009 Apr; 17(7):2913-9. PubMed ID: 19269185
[TBL] [Abstract][Full Text] [Related]
28. Fungal phenalenones inhibit HIV-1 integrase.
Shiomi K; Matsui R; Isozaki M; Chiba H; Sugai T; Yamaguchi Y; Masuma R; Tomoda H; Chiba T; Yan H; Kitamura Y; Sugiura W; Omura S; Tanaka H
J Antibiot (Tokyo); 2005 Jan; 58(1):65-8. PubMed ID: 15813183
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors.
Al-Mawsawi LQ; Dayam R; Taheri L; Witvrouw M; Debyser Z; Neamati N
Bioorg Med Chem Lett; 2007 Dec; 17(23):6472-5. PubMed ID: 17950601
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anti-HIV-1 integrase activities of 3-aroyl-2,3-dihydro-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sławiński J; Sanchez T; Neamati N
Eur J Med Chem; 2009 Jan; 44(1):190-6. PubMed ID: 18394758
[TBL] [Abstract][Full Text] [Related]
31. Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.
Wai JS; Kim B; Fisher TE; Zhuang L; Embrey MW; Williams PD; Staas DD; Culberson C; Lyle TA; Vacca JP; Hazuda DJ; Felock PJ; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Mallai R; Young SD
Bioorg Med Chem Lett; 2007 Oct; 17(20):5595-9. PubMed ID: 17822898
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel RAMP-independent CGRP receptor antagonist.
Zartman CB; Bell IM; Gallicchio SN; Graham SL; Kane SA; Mallee JJ; Rutledge RZ; Salvatore CA; Vacca JP; Williams TM
Bioorg Med Chem Lett; 2011 Nov; 21(22):6705-8. PubMed ID: 21982500
[TBL] [Abstract][Full Text] [Related]
33. The total synthesis of fukiic acid, an HIV-1 integrase inhibitor.
Queffélec C; Bailly F; Mbemba G; Mouscadet JF; Debyser Z; Witvrouw M; Cotelle P
Eur J Med Chem; 2008 Oct; 43(10):2268-71. PubMed ID: 18243421
[TBL] [Abstract][Full Text] [Related]
34. Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integrase.
Barreca ML; De Luca L; Iraci N; Chimirri A
J Med Chem; 2006 Jun; 49(13):3994-7. PubMed ID: 16789757
[TBL] [Abstract][Full Text] [Related]
35. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
[TBL] [Abstract][Full Text] [Related]
36. Integrase inhibitors.
García-Gasco P; Blanco F; Soriano V
J HIV Ther; 2005 Dec; 10(4):75-8. PubMed ID: 16519247
[No Abstract] [Full Text] [Related]
37. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N
ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063
[TBL] [Abstract][Full Text] [Related]
38. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
39. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
40. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
